Britannia Life Sciences Inc

Britannia Life Sciences Inc. is a global company specializing in the development and commercialization of products within the cosmetics, food, and nutraceutical sectors. With operations in the UK, Canada, Portugal, and the Channel Islands, they offer an integrated suite of services designed to support companies throughout the product development lifecycle. In addition to their focus on quality and regulatory compliance, Britannia Life Sciences operates PROOF Wellness, an eCommerce platform that provides consumers with access to top-quality wellness products validated by their accredited laboratory. Their commitment to innovation is further exemplified through partnerships in the cannabis industry and their strategic initiatives aimed at enhancing market access for CBD products in the UK. Generated from the website

Spectral Medical Inc., based in Toronto, Ontario, is a pioneering theranostic company committed to combating endotoxic septic shock through an innovative approach that combines rapid detection of endotoxin activity and targeted therapy. The company's flagship products include the Endotoxin Activity Assay (EAA) and the Toraymyxin PMX system, designed to effectively remove endotoxins from the bloodstream and improve patient outcomes in critical care settings. By leveraging precision medicine, Spectral evaluates therapies like the PMX hemoadsorption therapy through rigorous clinical trials, exemplified by their Tigris trial, which aims to enhance treatment strategies for sepsis. The company actively contributes to the advancement of sepsis care in collaboration with a myriad of stakeholders, demonstrating its commitment to transforming this critical area of medicine. Generated from the website

IntelliStem Technologies Brings revolutionary off-the-shelf cell therapy products to cancer patients by reprogramming stem cells to combat recurring and solid tumours. They create the next generation of cell therapy. Since its inception, the company has undergone steady growth, systemically building upon each research result and study to manufacture and develop programmable stem cell technology.